Mesoblast Stock Technical Analysis
| MESO Stock | USD 14.51 1.34 8.45% |
As of the 3rd of March, Mesoblast secures the insignificant Risk Adjusted Performance, standard deviation of 3.61, and Mean Deviation of 2.71. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of Mesoblast, as well as the relationship between them.
Mesoblast Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Mesoblast, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to MesoblastMesoblast | Build AI portfolio with Mesoblast Stock |
Mesoblast Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 35.0 | Strong Buy | 3 | Odds |
Most Mesoblast analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Mesoblast stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Mesoblast, talking to its executives and customers, or listening to Mesoblast conference calls.
Will Biotechnology sector continue expanding? Could Mesoblast diversify its offerings? Factors like these will boost the valuation of Mesoblast. Expected growth trajectory for Mesoblast significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mesoblast data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.85) | Revenue Per Share | Quarterly Revenue Growth 4.586 | Return On Assets | Return On Equity |
Investors evaluate Mesoblast using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Mesoblast's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Mesoblast's market price to deviate significantly from intrinsic value.
Understanding that Mesoblast's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mesoblast represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Mesoblast's market price signifies the transaction level at which participants voluntarily complete trades.
Mesoblast 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Mesoblast's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Mesoblast.
| 12/03/2025 |
| 03/03/2026 |
If you would invest 0.00 in Mesoblast on December 3, 2025 and sell it all today you would earn a total of 0.00 from holding Mesoblast or generate 0.0% return on investment in Mesoblast over 90 days. Mesoblast is related to or competes with Aprea Therapeutics, Adial Pharmaceuticals, Kiora Pharmaceuticals, Cardio Diagnostics, and Phio Pharmaceuticals. Mesoblast Limited engages in the development of regenerative medicine products in Australia, the United States, Singapor... More
Mesoblast Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Mesoblast's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Mesoblast upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.04) | |||
| Maximum Drawdown | 19.08 | |||
| Value At Risk | (6.32) | |||
| Potential Upside | 5.49 |
Mesoblast Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Mesoblast's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Mesoblast's standard deviation. In reality, there are many statistical measures that can use Mesoblast historical prices to predict the future Mesoblast's volatility.| Risk Adjusted Performance | (0) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.04) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Mesoblast's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Mesoblast March 3, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.03) | |||
| Mean Deviation | 2.71 | |||
| Coefficient Of Variation | (7,695) | |||
| Standard Deviation | 3.61 | |||
| Variance | 13.02 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.04) | |||
| Maximum Drawdown | 19.08 | |||
| Value At Risk | (6.32) | |||
| Potential Upside | 5.49 | |||
| Skewness | (0.30) | |||
| Kurtosis | 0.9912 |
Mesoblast Backtested Returns
Mesoblast has Sharpe Ratio of -0.0539, which conveys that the firm had a -0.0539 % return per unit of risk over the last 3 months. Mesoblast exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Mesoblast's Standard Deviation of 3.61, insignificant risk adjusted performance, and Mean Deviation of 2.71 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.53, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Mesoblast will likely underperform. At this point, Mesoblast has a negative expected return of -0.19%. Please make sure to verify Mesoblast's maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and price action indicator , to decide if Mesoblast performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.02 |
Virtually no predictability
Mesoblast has virtually no predictability. Overlapping area represents the amount of predictability between Mesoblast time series from 3rd of December 2025 to 17th of January 2026 and 17th of January 2026 to 3rd of March 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Mesoblast price movement. The serial correlation of 0.02 indicates that only 2.0% of current Mesoblast price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.02 | |
| Spearman Rank Test | 0.04 | |
| Residual Average | 0.0 | |
| Price Variance | 0.98 |
Mesoblast technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Mesoblast Technical Analysis
The output start index for this execution was two with a total number of output elements of fifty-nine. The Normalized Average True Range is used to analyze tradable apportunities for Mesoblast across different markets.
About Mesoblast Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Mesoblast on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Mesoblast based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Mesoblast price pattern first instead of the macroeconomic environment surrounding Mesoblast. By analyzing Mesoblast's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Mesoblast's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Mesoblast specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2023 | 2024 | 2026 (projected) | Days Sales Outstanding | 1.3K | 315.51 | 344.69 | PTB Ratio | 1.37 | 2.09 | 2.28 |
Mesoblast March 3, 2026 Technical Indicators
Most technical analysis of Mesoblast help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Mesoblast from various momentum indicators to cycle indicators. When you analyze Mesoblast charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0) | |||
| Market Risk Adjusted Performance | (0.03) | |||
| Mean Deviation | 2.71 | |||
| Coefficient Of Variation | (7,695) | |||
| Standard Deviation | 3.61 | |||
| Variance | 13.02 | |||
| Information Ratio | (0.04) | |||
| Jensen Alpha | (0.17) | |||
| Total Risk Alpha | (0.39) | |||
| Treynor Ratio | (0.04) | |||
| Maximum Drawdown | 19.08 | |||
| Value At Risk | (6.32) | |||
| Potential Upside | 5.49 | |||
| Skewness | (0.30) | |||
| Kurtosis | 0.9912 |
Mesoblast March 3, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Mesoblast stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 23,758 | ||
| Daily Balance Of Power | (2.23) | ||
| Rate Of Daily Change | 0.92 | ||
| Day Median Price | 14.67 | ||
| Day Typical Price | 14.62 | ||
| Price Action Indicator | (0.83) |
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mesoblast. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in main economic indicators. To learn how to invest in Mesoblast Stock, please use our How to Invest in Mesoblast guide.You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Will Biotechnology sector continue expanding? Could Mesoblast diversify its offerings? Factors like these will boost the valuation of Mesoblast. Expected growth trajectory for Mesoblast significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Mesoblast data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share (0.85) | Revenue Per Share | Quarterly Revenue Growth 4.586 | Return On Assets | Return On Equity |
Investors evaluate Mesoblast using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Mesoblast's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Mesoblast's market price to deviate significantly from intrinsic value.
Understanding that Mesoblast's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Mesoblast represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Conversely, Mesoblast's market price signifies the transaction level at which participants voluntarily complete trades.